Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

New treatments for hair loss are being developed using molecular biology.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Spironolactone effectively treats female pattern hair loss with few side effects.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.